DiscoverWIN 2017Proteogenomics in cancer research
Proteogenomics in cancer research

Proteogenomics in cancer research

Update: 2017-07-28
Share

Description

Dr Rodriguez speaks with ecancer at WIN 2017 about the translation of the proteins expressed in a patient's tumour into a map for druggable targets.

He highlights aspects of the Beau Biden Cancer Moonshot initiative, working with the National Cancer Institute, which aim to open global access to data libraries of tumour genomics and proteomics, including the APOLLO program and the International Cancer Proteogenome Consortium.
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Proteogenomics in cancer research

Proteogenomics in cancer research

Dr Henry Rodriguez - National Cancer Institute (NIH), Bethesda, USA